Contrast media-induced nephropathy (CN) is an important cause of hospital-acquired acute renal failure. Patients with both diabetes mellitus and renal impairment are at high risk. CN pathophysiology involves activation of the tubulo-glomerular feedback and vasoactive mediators such as renin-angiotensin 2, endothelin, adenosine, ADH, etc. The risk of CN can be minimized by the use of non-ionic, low or isoosmolar, contrast material, adequate hydration and prophylactic pharmacological measures. In patients with chronic renal failure who are undergoing arteriography (e.g. coronary angiography and angioplasty), periprocedural hemofiltration appears effective in preventing further renal damage due to contrast agents.
AlmenT.Relationship between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: EngeI., EdgrenJ. (eds). Patient safety and adverse events in contrast media examinations. Excerpta Medica International Congress series 816, Amsterdam - Elsevier Sciences Publisher, 1989: 25–45.
2.
MauerJ.H., ClaussW.A historical overview of the development of contrast media for diagnostic imaging procedures in radiology. In: DawsonP., ClaussW. (eds). Contrast media in practice.Springler Verlag, Berlin, 1993.
McCulloghP.A., WolynR., RocherLL. Acute renal failure after coronary intervention: incidence, risk factors, relationship with mortality.Am J Med1997; 103: 368–75.
28.
GrubergL., MintzG.S., MehranR. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existence of chronic renal insufficiency.JACC2000; 36: 1542–8.
29.
MorcosS.K., BrownP.W.G., OldroydS. Relationship between the diuretic effects of radiocontrast media and their ability to increase renal vascular resistence.Br J Radiol1995; 68: 850–3.
UedaJ., NygrenA., HansellP., UlfendahlH.R.Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in rat kidney.Acta Radiol1993; 34: 83–7.
32.
KatzbergR.W.Urography into the 21th century.Radiology1997; 204: 297–312.
33.
HeymanS.N., BrezisM., EpsteinFH. Early renal medullary hypoxic injury from radiocontrast and indomethacin.Kidney Int1991; 40: 632–42.
34.
ArakawaS., SuzukiH., NaitohM. Role of adenosine in renal response to contrast medium.Kidney Int1996; 49: 1199–206.
35.
OldroydS.D., HaylorJ.L., MorkosS.K.The acute effect of ioversol on kidney function: role of endothelin.Eur J Radiol1995; 19: 91–95.
36.
BrooksD.P., Dennis De PalmaP.Blockade of radiocontrast-induced nephrotoxicity by endothelin receptors antagonist.Nephron1996; 72: 629–32.
37.
BeeryR., SymonZ., BrezisM. Rapid DNA fragmentation from hypoxia along thick ascending limb of rat kidney.Kidney Int1995; 47: 1806–10.
38.
LieberthalW., LevineJ.Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury.Am J Physiol1996; 271: 477–88.
39.
PeerA., AverbukhZ., BermanS. Contrast media-induced apoptosis of cultured renal mesangial, tubular, epithelial, endothelial and hepatic cells.Invest Radiol2003; 38: 177–82.
40.
DawsonP.Contrast agent nephrotoxicity: an appraisal.J Radiol1985; 85: 121–4.
41.
BattenfeldR., KhaterA.R., DrommerW. Ioxaglate-induced light and electron microscope alterations in renal proximal tubular epithelium.Invest Radiol1991; 26: 35–40.
42.
WaldayP., HeglundI.F., GolmanR. Renal effects of iodixanol in experimental animals. 43.Acta Radiol1995; 36(Suppl. 399): 204–12.
43.
AndersenW., VikF., EikesdatH.P., Ilso ChristensenE.Effects of contrast media on renal epithelial cells in culture.Acta Radiol1995; 36(Suppl. 399): S213–8.
44.
LoveL., JohnsonM.S., BreslerME. The persistent CT nephrogram: its significance in contrast-associated nephrotoxicity.Br J Radiol1994; 67: 951–7.
45.
DobrotM., PowellC.J., HoltzE. Biochemical and morphological effects of contrast media on the kidney.Acta Radiol1995, 36 (Suppl 399), S196–203.
LeeJ.K.T., WarshauerD.M., BushWH. Determination of serum creatinine level before intravenous administration of iodinated contrast media.Invest Radiol1995; 30: 700–5.
48.
OlsenJ.C., SalomonB.Utility of the creatinine prior to intravenous contrast studies in the emergency department.J Emerg Med1996; 14: 543–6.
49.
RandersE., KristensenJ.H., ErlandsenE.J., DanielsenH.Serum cystatin-C as a marker of the renal function.Scand Clin Lab Invest1998; 58: 585–92.
50.
BurkhardtH., BojarskyG., GretzN. Creatinine clearance and Cystatin-C: estimators of the true glomerular filtration rate in elderly.Gerontology2002; 48: 140–6.
51.
JakobsenJ.A.Renal effects of iodixanol in healthy volunteers and patients with severe renal failure.Acta Radiol1995. 36 (Suppl. 399): S191–5.
52.
DerayG, JacobsC.Toxicité rénale des produits de contraste iodés.Prèsse Med1997; 26: 190–4.
53.
WaybillM.M., WaybillP.N.Contrast media-induced nephrotoxicity: identification of patients of risk and algorithms for prevention.J Vasc Interv Radiol2001; 12: 3–9.
ChalmersN., JacksonR.W.Comparison of iodixanol and iohexol in renal impairment.Br J Radiol1999; 72: 701–3.
56.
CarraroM., MatalanF., AntonioneR. Effects of a dimeric vs a monomeric nonionic contrast medium in renal function in patients with mild to moderate renal insufficiency.Eur Radiol1998; 8: 144–7.
57.
SandlerC.M.Contrast agent-induced acute renal failure: is iodixanol the answer?N Engl J Med2003; 348: 551–3.
58.
StaculF., CovaM., AssanteM. Comparison between dimeric and monomeric nonionic contrast media(iodixanol vg iopromide)in urography in patients with mild to moderate renal insufficiency.Br J Radiol1998; 71: 918–22.
59.
KolehmainenH., SoivaM.Comparison of Xenetix 300 and Visipaque 300 in patients with renal failure.Eur Radiol2003; 13: B32–33.
StaculF., BertrandM.E., McCulloghT.A., BrincherJ.A.Contrast-induced nephropathy following isoosmolar versus low-osmolar contrast media in patients undergoing angiography.Comun. Convegno Europeo Radiologia, Vienna, Marzo 2004.
62.
ForniG.D., HiltonP.J.Continous hemofiltration in the treatment of acute renal failure.N Engl J Med1997; 336: 1303–9.
63.
MarenziW., MaranaI., LauriGF. The prevention of radio-contrast agent-induced nephropathy by hemofiltration.N Eng J Med2003; 349: 1333–40.
64.
MorcosS.K., ThomsenH.S., WebbJA. Dialysis and contrast media.Eur Radiol2002; 12: 3026–30.
65.
CarraroM., ManciniW., ArteroM. Dose effects of nitrendipine on urinary enzymes and microproteins following nonionic ray-contras administration.Nephrol Dial Transplant1996; 11: 444–8.
66.
ErleyC.M., DudaS.H., RehfussD. Prevention of radiocontrast media-induced nephropathy in patients with pre-existing renal insufficiency by hydratation, in combination with the adenosine antagonist theophylline.Nephrol Dial Transplant1999; 14: 1146–9.
67.
OldroydS.D., HaylorJ.L., MorcosS.K.Bosentan, an orally active endothelin-antagonist: effect on the renal response to contrast media.Radiology1995; 196: 661–5.
68.
SketchM.H., WheltonA., SchollmayerE. Prevention of contrast media induced nephropathy with PGE-1.Am J Therap2001; 8: 155–6.
69.
RussoD., MinutoloR., CianciarusoB. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure.J Am Soc Nephrol1995; 6: 1451–8.
AgostoniA.Vasopeptidasi e loro inibitori.Rec Progr Med2002; 93: 519–22.
72.
HansS.S., HansB.A., DhillonR. Effect of dopamine on renal function after arteriography in patients with preexisting renal insufficiency.Am Surg1998; 64: 432–6.
73.
KiniA.S., MitreC.A., KimM. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopan.Catheter Cardiovasc Interv2002; 55: 169–73.
74.
AbizaidA.S., ClarkC.E., MintzGS. Effects of dopamine and aminophylline on contrast-induced failure after coronary angioplasty in patients with preexisting renal insufficiency.Am J Cardiol1999; 83: 260–3.
75.
StaculF., CovaM.Nefrotossicità da mezzi di contrasto: quali problemi nella pratica clinica?.Radiol Med, 2002; 105: 36–41.
76.
TepelM., Van Der GietM., SchwarzfeldC. Prevention of radiographic contrast-agent-induced reduction in renal function by acetylcysteine.N Engl J Med; 2000: 343: 180–4.
77.
BakrisG.L., LassN., GaberAO. Radiocontrast medium-induced declines in renal function: role for oxygen free radicals.Am J Physiol1990; 258: F115–119.
78.
BriguoriC., ManganelliF., ScarpatoP. Acetylcysteine and contrast agent-associated nephrotoxicity.J Am Coll Cardiol2002; 89: 356–8.
79.
RizzatoG.F.Sorprendente ma vero: 1'N-acetilcisteina protegge dai danni renali provocati dai mezzi di contrasto iodati.Radiol Med2001; 101: 287–9.
80.
EriksonC.W., EriksonJ.E., WilskerG., BrunnerL.A retrospective analysis of oral acetylcysteine to prevent X-ray contrast-induced nephropathy in patients undergoing coronary angiography with elevated serum creatinine.Am J Kidney Dis2002; 39: A16.
81.
ValleroA., CesanoG., PozzatoM. Nefropatia da mezzo di contrasto in cardiologia interventistica: assenza di vantaggi con impiego profilattico di N-acetilcisteina.G Ital Nefrol2002; 19: 529–33.
82.
NallamothuB.K., ShojaniaK.G., SaintS. Is acetylcysteine effective in preventing contrast-related nephropathy?Am J Med2004; 117: 938–47.
83.
ShahS.J., HsuC.Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients?Am J Med2004; 117: 948–52.
84.
SolomonR., WernerC., MannD., SilvaP.Effects of saline, mannitol furosemide on acute decrease in renal function induced by radiocontrast agents.N Engl J Med1994; 331: 1416–20.
85.
LissP., NyegrenA., OlssonH. Effects of contrast media and mannitol on renal medullary blood.Kidney Int1996; 49: 1268–75.
86.
PondG.D., SmythS.H., RoachDJ. Metformin and contrast media.Radiology1996; 201: 879–80.
87.
WangX.Y., HussainS.M., KrestinG.P.Super-paramagnetic iron oxide contrast agents: physicochemical characteristics and applications in MRI.Eur Radiol2001; 11: 2319–31.
88.
AnzaiY., PiccoliC.W., OutwaterEK. Evaluation of neck and body metastases with ferumoxtran enhanced MR-imaging: phase III safety and efficacy study.Radiology2003; 228: 778–88.
89.
MorelD., SchwiegerI., HolnL. Human pharmacokinetics and safety of sonovue, a new contrast agent ultrasound imaging.Invest Radiol2000; 35: 80–5.
90.
GoddiA., NotarioR., TanziF. Analisi del comportamento di un ecocontrasto di seconda generazione in soluzione fisiologica.Radiol Med2004; 107: 569–78.
91.
DrudiF.Considerazioni sui mezzi di contrasto ultrasonografici.Radiol Med2004; 107(Suppl. 1): S36–7.
92.
DuongM.H., MacKenzieT.A., MalenkaD.J.N-acetylcysteine prophilaxis significantly reduces the risk of radiocontrast-induced nephropathy.Catheter Cardiovasc Interv2005; 64: 471–9.
93.
AsifA., GargesG., PrestonR.A., RothD.Current trials of interventions to prevent radiocontrast-induced nephropathy.Am J Ther2005; 12: 127–32.
94.
LinJ., BonventreJ.V.Prevention of radiocontrast nephropathy.Curr Opin Nephrol Hypertens2005; 14: 105–10.
